Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation stock sinks to 52-week low territory after 6% Friday slide — what to watch next for NYSE:VIA

Via Transportation shares fell 6.3% Friday to $27.18, near their 52-week low and about 41% below the company’s $46 IPO price from September. The drop came as the S&P 500 rose and mobility peers Uber and Lyft gained. Investors await key U.S. jobs and inflation data next week. Via remains unprofitable and faces risks from public-sector spending and regulatory challenges.
4 January 2026
Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences (WVE) stock slides 6% — what traders are watching next

Wave Life Sciences shares fell 6.2% to $15.95 Friday, underperforming the flat Nasdaq Biotechnology Index. The company expects more Phase 1 obesity trial data in Q1 2026. A December SEC filing said Wave’s equity raise, including over-allotments, was expected to bring in about $402.5 million. Early data showed WVE-007 reduced visceral fat by 9.4% at three months in a 32-person cohort.
4 January 2026
Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo Group (XZO) stock drops 6% into weekend — what investors are watching next

Exzeo shares fell 6.1% to $22.76 Friday, with trading volume jumping to 424,000 shares from 240,000 the previous session. The stock touched a low of $22.19 and a high of $24.49 during the day. Exzeo’s next earnings report is due Feb. 25. HCI Group, which owns 81.5% of Exzeo, disclosed its CEO Paresh Patel adopted a plan to buy up to 100,000 shares if prices drop further.
4 January 2026
Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next

Kymera Therapeutics shares fell 6.5% to $72.76 on Friday, marking a seventh straight daily loss and leaving the stock down 29% from its early December peak. About 854,000 shares traded as investors shifted focus to 2026 trial milestones and funding. CEO Nello Mainolfi sold 30,000 shares in a pre-arranged plan on Dec. 31. The company raised $602 million in a December stock offering at $86 per share.
4 January 2026
Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software stock slides 6.7% into weekend; what GWRE investors watch next

Guidewire Software shares fell 6.7% to $187.63 on Friday, closing below key moving averages after a quiet news period. The stock’s 14-day RSI neared 30, signaling oversold conditions, as investors awaited U.S. jobs data and Guidewire’s next earnings in March. About 806,660 shares traded in a session marked by light volume. Guidewire last reported Q1 revenue of $332.6 million and raised its fiscal-year outlook in December.
4 January 2026
BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL stock slides 7% to start 2026 despite KBW target raise — what to watch Monday

BILL Holdings shares fell 7.3% to $50.56 Friday, marking one of their steepest single-day drops in weeks. Keefe, Bruyette & Woods raised its price target to $60 but maintained a “market perform” rating. The decline came as the S&P 500 rose 0.19% and the Nasdaq was flat. BILL’s next key events include a Jan. 16 finance leadership change and an earnings update expected in early February.
1 258 259 260 261 262 535

Stock Market Today

CBA share price: Commonwealth Bank stock steadies after ASX selloff as earnings loom

CBA share price: Commonwealth Bank stock steadies after ASX selloff as earnings loom

8 February 2026
Commonwealth Bank of Australia closed Friday down 0.23% at A$158.91, outperforming a 2.03% drop in the S&P/ASX 200. Investors await CBA’s half-year results on Feb. 11 and commentary from CEO Matt Comyn. The Reserve Bank’s recent cash-rate hike to 3.85% and upcoming mortgage repricing are in focus. CBA flagged A$68 million in provisions and A$53 million in non-recurring income items.
Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

8 February 2026
Boeing shares closed up 2.6% at $243.03 Friday, buoyed by reports of possible major aircraft orders from Saudi Arabia and India. India’s trade minister said a $70–80 billion Boeing deal could be signed by March. Supply-chain delays and regulatory scrutiny remain key risks. Boeing’s chief engineer sold over 10,000 shares earlier in the week.
Go toTop